Newsletter

Small Caps Stocks

ASX Biotech Investing In 2026: Investors Are More Aware Of The Hard Lessons, But Have Forgotten The Hidden Rewards Of It

ASX Biotech Investing has always been the market’s most difficult arena. Yes tech and resources are risky spaces too, but at least a gold explorer can gain just off the back of gold price momentum or activity from neighbouring peers. With biotech it is all on the success of the individual company. The science is extraordinary…

ByNick SundichApril 7, 2026

The Long Goodbye: Why Australian Active Fund Managers Are Running Out of Road

Australian Active Fund Managers are struggling, make no mistake. Hitting home the point yesterday were reports that Ox Capital Management — a boutique emerging markets specialist led by veteran investor Joseph Lai; had entered formal wind-up proceedings on March 27 2026. This wind up was not the first, and likely won't be the last. So each…

ByNick SundichApril 2, 2026

Here are 7 ASX 200 Stocks Winning During The Iran War…And Aren’t In The Soaring Oil and Gas Space!

Investors asked to name ASX 200 stocks winning during the Iran war would likely think of oil and gas stocks, benefiting from soaring prices. This is not incorrect - oil stocks like Woodside, Santos and Karoon have grabbed the headlines as the obvious beneficiaries of the US-Iran conflict that erupted in late February 2026. However, they'd…

ByNick SundichApril 1, 2026

This Is The ASX Fertiliser Stock Positioned At The Right Place At the Right Time!

It is a good time to be in an ASX Fertiliser Stock, if ever there was one. The global fertiliser industry is facing its most severe supply crisis in a generation, and the companies best positioned outside the danger zones could emerge as the biggest winners. Two seismic events have collided to reshape the market:…

ByNick SundichMarch 31, 2026

The Koala IPO Went Well With a Solid Gain On Debut! But Now What?

The Koala IPO went off without a hitch. The furniture company hit the ASX boards earlier today (March 31 2026) and did well out of the gate, rewarding investors who secured an allocation in the offer as well as those who'd been around for years, one of whom was Steve Smith. As of 2.30pm Tuesday,…

ByNick SundichMarch 31, 2026

Here Are 6 Questions Investors Need To Ask About Their Portfolio To Get The Best Possible Returns!

There are hard questions investors need to ask about their portfolio every now and again, because anyone telling you there's such a thing as a 'set and forget' investment is wrong. Markets evolve, company fundamentals shift, and macro conditions change, yet many portfolios are left largely unchecked. The most rational approach is to periodically interrogate…

ByNick SundichMarch 31, 2026

The Impact of The Iran War Extends Beyond Oil, And this ASX Company is the Poster Child for It!

It is easy to think the Impact of The Iran War is simply businesses in the oil space or that use oil in their operations (for instance freight businesses). Or by extension, companies in the 'consumer discretionary' space that find due to higher energy prices (and interest rates), that their goods are more discretionary than…

ByNick SundichMarch 25, 2026

The final building block for Eco-Clay’s rollout is here thanks to a deal between Green360 Technologies (ASX:GT3) and Calix (ASX:CXL)!

The potential of Green360 Technologies' (ASX:GT3) Eco-Clay has been well-established, but getting it to market was never going to be a mean feat. Nonetheless, a major step was realised in the form of a toll-treatment agreement covering 30,000tpa with fellow ASX listee Calix (ASX:CXL). This is a big deal, above all else because it paves the…

ByNick SundichMarch 24, 2026

Brett Blundy buying into weakness as Lovisa’s chart tests conviction

Brett Blundy has always been at his most interesting when the market is uncertain. His latest buying in Lovisa is not a confirmation of strength. It is a statement that he believes the business is holding up better than the share price suggests. That distinction matters. The share price has drifted lower, and the chart is not…

ByCharlie YouldenMarch 24, 2026

Murray Cod Australia (ASX: MCA) Scaling is working, but the market is still waiting for cash

Scaling is working, but the market is still waiting for cash The share price of Murray Cod Australia has not followed a smooth trajectory over the past twelve months. It has been defined by weakness for much of the period, followed by a sharp recovery in March after insider buying triggered a re-rating. That move was…

ByCharlie YouldenMarch 24, 2026

the Kick-ass Multipurpose WordPress Theme

Small Caps Stocks

ASX Biotech Investing In 2026: Investors Are More Aware Of The Hard Lessons, But Have Forgotten The Hidden Rewards Of It

The Long Goodbye: Why Australian Active Fund Managers Are Running Out of Road

Here are 7 ASX 200 Stocks Winning During The Iran War…And Aren’t In The Soaring Oil and Gas Space!

This Is The ASX Fertiliser Stock Positioned At The Right Place At the Right Time!

The Koala IPO Went Well With a Solid Gain On Debut! But Now What?

Here Are 6 Questions Investors Need To Ask About Their Portfolio To Get The Best Possible Returns!

The Impact of The Iran War Extends Beyond Oil, And this ASX Company is the Poster Child for It!

The final building block for Eco-Clay’s rollout is here thanks to a deal between Green360 Technologies (ASX:GT3) and Calix (ASX:CXL)!

Brett Blundy buying into weakness as Lovisa’s chart tests conviction

Murray Cod Australia (ASX: MCA) Scaling is working, but the market is still waiting for cash

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Small Caps Stocks

Stocks in Spotlight

Add Your Heading Text Here